🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 31,52 32,16 30,65 31,96 -0,71% 4,79% 869.200
01/02/2024 32,25 32,37 31,25 32,19 +0,28% 3,47% 931.200
31/01/2024 32,91 33,36 31,79 32,10 -2,76% 4,77% 872.400
30/01/2024 34,19 34,39 32,94 33,01 -4,04% 4,24% 594.500
29/01/2024 32,62 34,46 31,99 34,40 +5,04% 7,57% 751.200
26/01/2024 33,67 33,77 32,56 32,75 -2,00% 3,61% 538.800
25/01/2024 33,00 33,87 32,86 33,42 +1,86% 3,06% 678.600
24/01/2024 34,58 34,95 32,78 32,81 -4,32% 6,28% 812.900
23/01/2024 33,89 34,50 33,42 34,29 +3,31% 3,19% 1.233.900
22/01/2024 33,83 33,93 32,58 33,19 -1,66% 3,99% 1.409.200
19/01/2024 33,32 34,15 32,90 33,75 +1,78% 3,75% 996.100
18/01/2024 34,39 34,39 32,71 33,16 -2,64% 4,89% 1.501.000
17/01/2024 34,40 34,77 33,48 34,06 -2,94% 3,75% 1.073.700
16/01/2024 36,03 36,03 34,32 35,09 -3,68% 4,75% 1.381.400
12/01/2024 37,62 37,62 35,56 36,43 -2,85% 5,48% 1.495.100
11/01/2024 39,22 39,54 37,36 37,50 -4,94% 5,56% 2.181.900
10/01/2024 38,24 39,83 37,71 39,45 +3,62% 5,54% 1.841.600
09/01/2024 38,91 39,65 37,26 38,07 -3,57% 6,13% 2.075.600
08/01/2024 35,10 39,53 34,37 39,48 +10,90% 14,70% 5.170.100
05/01/2024 33,89 35,99 33,32 35,60 +3,10% 7,88% 2.973.900
04/01/2024 32,63 34,80 32,59 34,53 +8,01% 6,77% 5.694.000
03/01/2024 32,65 34,31 31,15 31,97 +3,10% 9,66% 6.019.500
02/01/2024 30,50 32,15 29,65 31,01 +1,34% 8,20% 791.900
29/12/2023 31,22 31,68 30,55 30,60 -1,29% 3,62% 815.700
28/12/2023 30,88 31,57 30,52 31,00 -0,10% 3,40% 911.100
27/12/2023 31,05 31,55 30,53 31,03 +0,45% 3,29% 667.600
26/12/2023 30,68 31,17 30,10 30,89 +1,78% 3,49% 675.400
22/12/2023 29,00 30,44 28,96 30,35 +5,53% 5,10% 945.500
21/12/2023 28,33 28,90 28,12 28,76 +3,34% 2,74% 977.400
20/12/2023 29,90 30,00 27,77 27,83 -7,23% 7,46% 1.085.800